• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2013 Fiscal Year Final Research Report

Investigation of the relationship between opioid kappa receptor subtype and receptor dimerization

Research Project

  • PDF
Project/Area Number 23590133
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Drug development chemistry
Research InstitutionKitasato University

Principal Investigator

FUJII Hideaki  北里大学, 薬学部, 教授 (30458757)

Co-Investigator(Renkei-kenkyūsha) NAGASE Hiroshi  筑波大学, 国際統合睡眠医科学研究機構, 教授 (70383651)
UEZONO Yasuhito  独立行政法人国立がん研究センター, 研究所, 部長 (20213340)
HIRAYAMA Shigeto  北里大学, 薬学部, 助教 (40565842)
Project Period (FY) 2011 – 2013
Keywords医薬分子設計 / 受容体ダイマー / オピオイド / κ作動薬 / ファーマコフォー
Research Abstract

On the basis of our 3D pharmacophore model of kappa agonists, compounds belonging to the binding mode 1, 3, or 4 were synthesized and their binding affinities and agonistic activities for the opioid receptors were evaluated. The test compounds showed selective binding abilities and agonistic activities for the kappa receptor although the strengths of bindings and activities depended on the structures. The binding modes of the compounds were not observed to affect the impedance patterns detected by CellKey SystemTM which was used in the functional assays.

  • Research Products

    (10 results)

All 2014 2013 2012

All Journal Article (6 results) (of which Peer Reviewed: 6 results) Presentation (4 results)

  • [Journal Article] Novel Delta Opioid Receptor Agonists with Oxazatricyclodecane Structure2014

    • Author(s)
      Fujii, H.; Hayashida, K.; Saitoh, A.; Yokoyama, A.; Hirayama, S.; Iwai, T.; Nakata, E.; Nemoto, T.; Sudo, Y.; Uezono, Y.; Yamada, M.; Nagase, H
    • Journal Title

      ACS Med. Chem. Lett

      Volume: 5 Pages: 368−372

    • DOI

      10.1021/ml400491k

    • Peer Reviewed
  • [Journal Article] Essential Structure of theκOpioid Receptor Agonist Nalfurafine for Binding to theκReceptor2013

    • Author(s)
      Nagase, H.; Fujii, H
    • Journal Title

      Curr. Pharmacuet. Des

      Volume: 19 Pages: 7400–7414

    • DOI

      10.2174/138161281942140105162601

    • Peer Reviewed
  • [Journal Article] The effect of 17-N substituents on the activity of the opioidκreceptor in nalfurafine derivatives2013

    • Author(s)
      Nemoto, T.; Hirayama, S.; Iwai, T.; Yamamoto, N.; Harada, Y.; Wada, N.; Tomatsu, M.; Ishihara, M.; Fujii, H.; Nagase, H
    • Journal Title

      Bioorg. Med. Chem. Lett

      Volume: 23 Pages: 268–272

    • DOI

      10.1016/j.bmcl.2012.10.100

    • Peer Reviewed
  • [Journal Article] Essential structure of opioidκreceptor agonist nalfurafine for binding to theκreceptor 3: Synthesis of decahydro(iminoethano)phenanthrene derivatives with an oxygen functionality at the 3-position and their pharmacologies2012

    • Author(s)
      Fujii, H.; Imaide, S.; Hirayama, S.; Nemoto, T.; Gouda, H.; Hirono, S.; Nagase,H
    • Journal Title

      Bioorg. Med. Chem. Lett

      Volume: 22 Pages: 7711–7714

    • DOI

      10.1016/j.bmcl.2012.09.101

    • Peer Reviewed
  • [Journal Article] Essential structure of opioidκreceptor agonist nalfurafine for binding to theκreceptor 2: Synthesis of decahydro(iminoethano)phenanthrene derivatives and their pharmacologies2012

    • Author(s)
      Nagase, H.; Imaide, S.; Hirayama, S.; Nemoto, T.; Fujii, H
    • Journal Title

      Bioorg. Med. Chem. Lett

      Volume: 22 Pages: 5071–5074

    • DOI

      10.1016/j.bmcl.2012.05.122

    • Peer Reviewed
  • [Journal Article] Essential structure of opioidκreceptor agonist nalfurafine for binding toκreceptor 1: Synthesis of decahydroisoquinoline derivatives and their pharmacologies2012

    • Author(s)
      Nagase, H.; Imaide, S.; Yamada, T.; Hirayama, S.; Nemoto, T.; Yamaotsu, N.; Hirono, S.; Fujii, H
    • Journal Title

      Chem. Pharm. Bull

      Volume: 60 Pages: 945–948

    • DOI

      10.1248/cpb.c12-00336

    • Peer Reviewed
  • [Presentation] CellKey^<TM>システムを用いた作動活性評価とそれに基づく選択的オピオイドκ受容体作動薬ナルフラフィンの必須構造の検討2014

    • Author(s)
      藤井秀明、今出慧海、横山明信、須藤結香、平山重人、岩井孝志、山田貴明、根本徹、上園保仁、長瀬博
    • Organizer
      日本薬学会第134年会
    • Place of Presentation
      熊本
    • Year and Date
      2014-03-28
  • [Presentation] オキサアザトリシクロデカン骨格を有する新規オピオイドδ受容体作動薬の設計と合成、およびその薬理作用22013

    • Author(s)
      藤井秀明、林田康平、渡邉義一、齊藤大祐、高橋俊弘、酒井潤一、田中恵理子、神田貴史、岩井孝志、平山重人、根本徹、山川富雄、長瀬博
    • Organizer
      第33回鎮痛薬・オピオイドペプチドシンポジウム
    • Place of Presentation
      神戸
    • Year and Date
      2013-09-07
  • [Presentation] CellKey™systemを用いた新規δオピオイド受容体特異的アゴニストの開発及びスクリーニング2013

    • Author(s)
      横山明信、須藤結香、宮野加奈子、鈴木雅美、白石成二、平山重人、林田康平、藤井秀明、酒井潤一、神田貴史、中田恵理子、長瀬博、樋上賀一、上園保仁
    • Organizer
      第86回日本薬理学会年会
    • Place of Presentation
      福岡
    • Year and Date
      2013-03-22
  • [Presentation] オキサアザトリシクロデカン骨格を有する新規オピオイドδ受容体作動薬の設計と合成、およびその薬理作用2012

    • Author(s)
      藤井秀明、林田康平、平山重人、岩井孝志、根本徹、酒井潤一、神田貴史、中田理恵子、上園保仁、長瀬博
    • Organizer
      第32回鎮痛薬・オピオイドペプチドシンポジウム
    • Place of Presentation
      東京
    • Year and Date
      2012-09-16

URL: 

Published: 2015-07-16  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi